PharmiWeb1h
Cellev8 Nutrition Teams Up With NFL Hall of Famer Andre Reed to Revolutionize Wellness, on and Off the Field
Cellev8's Brand Expands Beyond Consumers  WELLINGTON, FLORIDA / ACCESSWIRE / January 15, 2025 / Cellev8 Nutrition Inc., a leader in natural health supplements, is proud to announce an exclusive ...
PharmiWeb1h
Handa Therapeutics Acquires FDA Approved Chronic Myeloid Leukemia Drug, PHYRAGO (dasatinib) Tablets
PHYRAGO™ Represents the First and Only Improved Version of SPRYCEL® That Can Be Safely Co-administered With Gastric Acid-Reducing Agents TAIPEI, TAIWAN / ACCESSWIRE / January 15, 2025 / Handa ...
PharmiWeb9h
BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy
BioMed X, an independent biomedical research institute based in Heidelberg, Germany, announced today the launch of a new ...
PharmiWeb3h
Black Book Research Announces the Release of "The 2025 Black Book of Healthcare IT Consultants and Advisory Firms"
Comprehensive Gratis Report Featuring Profiles and Client Engagement Ratings for 260 HIT Consulting and Advisory Firms TAMPA, FLORIDA / ACCESSWIRE / January 15, 2025 / Black Book Research announces ...
PharmiWeb3h
Laxxon Medical Announces Positive Pilot PK Study Results (in Pigs) for Groundbreaking Oral GLP-1 Dosage Form
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug delivery systems, today announced the ...
PharmiWeb3h
Mentavi Health Announces Results From First-of-Its-Kind ADHD Assessment Validation Study
Innovative Research Confirms Accuracy and Reliability of Online ADHD Diagnostic Evaluation GRAND RAPIDS, MICHIGAN / ACCESSWIRE / January 15, 2025 / Mentavi Health, a leader in evidence-based mental ...
PharmiWeb3h
Telangiectasia Treatment Now Available at Skin & Laser Dermatology Center
Dr. Amir Bajoghli and Skin & Laser Dermatology Center are excited to introduce advanced laser treatments for telangiectasia, offering patients effective solutions to reduce the appearance of small, ...
PharmiWeb5h
Aptevo's Peter Pavlik, PhD, Chairing Session on "Bi and Multispecific Biologics" at Cambridge Healthcare Institute's Pep Talk 2025
Also giving an in-session talk titled "Modular Multispecific Biotherapeutics: Rapid Therapeutic Design with the ADAPTIR® Platform," showcasing Aptevo's drug engineering and rational drug design ...
PharmiWeb5h
Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer
FORT LAUDERDALE, FL / ACCESSWIRE / January 15, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...
PharmiWeb7h
Rancho Biosciences and ONTOFORCE Collaborate to Leverage High Quality Data for Target Identification
SAN DIEGO, CALIFORNIA / ACCESSWIRE / January 15, 2025 / Rancho BioSciences, the premier tech-enabled data science partner for biopharma, headquartered in San Diego, California, is excited to announce ...
PharmiWeb8h
Oxford Drug Design achieves further in vivo validation of novel approach against multiple tumours
Oxford Drug Design, the Oxford-based AI drug discovery company, has today announced additional in vivo validation for its first-in-class approach against cancer as the Company continues to apply its ...
PharmiWeb8h
Researchers uncover what drives aggressive bone cancer
Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a ...